Veeva Systems Inc Class A (VEEV)
Veeva Systems Inc Class A (VEEV) carries a ŷRobot AI score of 42 out of 100. The model's fair value estimate is $270.14, 10.4% below the last close of $301.57. The chart signal reads Hold.
| Metric | VEEV |
|---|---|
| AI score | 42 / 100 |
| Chart signal | Hold |
| Fair value estimate | $270.14 |
| Upside to fair value | -10.4% |
| Previous close | $301.57 |
| P/E | 45.67 |
| Price / sales | 13.20 |
| Market cap | $48.96B |
| EPS | 6.25 |
| Revenue growth | 13.4% |
| 1-year price change | 6.8% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about VEEV
Is VEEV overvalued or undervalued right now?
As of Oct 2, 2026, ŷRobot's fair-value model estimates Veeva Systems Inc Class A (VEEV) at $270.14 against a last close of $301.57, implying 10.4% downside to the model's estimate.
Is VEEV's chart signal bullish or bearish?
The chart-signal model classifies VEEV as Neutral as of Nov 13, 2026, with a signal score of -0.06 on a -1 to 1 scale.
What is VEEV's ŷRobot AI score?
VEEV scores 42 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is VEEV stock expensive on P/E and P/S?
VEEV trades at 45.7 times earnings and 13.2 times sales as of Nov 13, 2026.
What does VEEV's seasonal forecast show?
ŷRobot's seasonal forecast curve for VEEV reads -3.1% at 30 days, -3.2% at 90 days, and +6.8% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is VEEV growing?
Veeva Systems Inc Class A's revenue growth is +13.4% and free-cash-flow growth is -4.5% on the latest reported figures.
VEEV chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.